From: Somatic structural rearrangements in genetically engineered mouse mammary tumors
Number of samples | Genotype | Latency (days) | Homologous repair | p53 status | Reference | Identifiers | Histology | Tumor (%) |
---|---|---|---|---|---|---|---|---|
2 | K14cre;Trp53 flox/flox | 504 | Proficient | Heterozygous | Jonkers et al. 2001 [20] | PD3685a | Mesenchymal | 75 |
 |  | 386 |  |  |  | PD3686a | Mesenchymal | 50 |
2 | K14cre;Cdh1 flox/flox ;Trp53 flox/flox | 449 | Proficient | Null | Derksen et al. 2006 [19] | PD3679a | mILCa | 85 |
 |  | 328 |  |  |  | PD3680a | mILCa/Carcinoma | 85 |
2 | K14cre;Brca1 flox/flox ;Trp53 flox/flox | 99 | Deficient | Null | Liu et al. 2007 [21] | PD3681a | Carcinoma | 95 |
 |  | 247 |  |  |  | PD3682a | Carcinoma | 95 |
2 | K14cre;Brca2 flox/flox ;Trp53 flox/flox | 144 | Deficient | Null | Jonkers et al. 2001 [20] | PD3683a | Carcinoma | 95 |
 |  | 227 |  |  |  | PD3684a | Carcinoma | 95 |